11/26
11:06 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA
11/26
11:06 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA
11/26
08:00 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock, down previously from $22.00.
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock, down previously from $22.00.
11/26
08:00 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock, down previously from $22.00.
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock, down previously from $22.00.
11/26
07:50 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA
11/26
07:50 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA
10/10
08:40 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
10/9
02:40 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
10/9
02:40 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
10/9
02:07 pm
enta
Rating for ENTA
Low
Report
Rating for ENTA
10/9
02:07 pm
enta
Rating for ENTA
Low
Report
Rating for ENTA
9/27
11:05 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
9/27
11:05 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $22.00 price target on the stock.
9/27
10:46 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA
9/27
10:46 am
enta
Rating for ENTA
Medium
Report
Rating for ENTA